drugset / Trial / NCT00708539

A Prospective Randomized Multicentre Study to Compare Crinone 8% Once Daily Versus Other Vaginal Progesterone.

NCT00708539

RandomizedParallel-groupSingle-blindTreatment

Summary

To compare the effect of Crinone 8% administered once daily versus other vaginal progesterone in terms of ongoing pregnancy rate 5 weeks after embryo transfer as well as patient convenience.

Timeline

Start
2006-04
Primary completion
2008-12
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Progesterone Other / unclassified 90 mg Other
Comparator Progesterone Other / unclassified 200 mg Other
Comparator Progesterone Other / unclassified 400 mg Other

Indications

No indication recorded.